Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
12/11/2003 | US20030229023 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents |
12/11/2003 | US20030229002 Use of agents that modulate PDE11A activity |
12/11/2003 | US20030228380 Central nervous system diosrders; reduction of estrogen after menopause |
12/11/2003 | US20030228365 Pharmaceutical formulation |
12/11/2003 | CA2490051A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate |
12/11/2003 | CA2487905A1 Use of cgmp - stimulating compounds |
12/11/2003 | CA2487639A1 Self-administered contraceptive injection of oily solution |
12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
12/11/2003 | CA2487293A1 Use of new etonogestrel esters |
12/11/2003 | CA2486980A1 Attenuated listeria spp. and methods for using the same |
12/11/2003 | CA2486174A1 Xanthine phosphodiesterase v inhibitor polymorphs |
12/11/2003 | CA2483834A1 Norethindrone sustained release formulations and methods associated therewith |
12/11/2003 | CA2482639A1 3-substituted quinuclidines and their use |
12/10/2003 | EP1368469A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
12/10/2003 | EP1368357A1 Tricyclic quinolinone and tricyclic quinoline as androgen receptor modulator compounds |
12/10/2003 | EP1368353A1 2-alkoxyphenyl substituted imidazotriazinones |
12/10/2003 | EP1368352A1 Cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors |
12/10/2003 | EP1368348A1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives |
12/10/2003 | EP1368346A1 Substituted benzofuran-2-carboxamides derivatives |
12/10/2003 | EP1368344A1 Piperazine derivatives, their preparation and uses in therapy (5ht1b receptor activity) |
12/10/2003 | EP1368340A1 Piperazine derivatives as melanocortin receptor agonists |
12/10/2003 | EP1368339A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
12/10/2003 | EP1368320A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
12/10/2003 | EP1368319A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
12/10/2003 | EP1368314A1 N-4-piperidinyl compounds as ccr5 modulators |
12/10/2003 | EP1368312A1 Benzo'f!isoindole derivatives with affinity to the ep4 receptor |
12/10/2003 | EP1368302A1 Novel amino dicarboxylic acid derivatives |
12/10/2003 | EP1368301A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
12/10/2003 | EP1368094A1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
12/10/2003 | EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses |
12/10/2003 | EP1368037A2 Estrogen replacement therapy |
12/10/2003 | EP1368012A2 Use of one or more shogaol(s) as an aphrodisiac |
12/10/2003 | EP1368002A2 Method for producing a floating tablet containing alfuzosine |
12/10/2003 | EP1367999A2 Water soluble and palatable complexes |
12/10/2003 | EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
12/10/2003 | EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/10/2003 | EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
12/10/2003 | EP1185276B1 Isophosphoramide mustard analogs and use thereof |
12/10/2003 | EP0671924B1 Digitalis-like compounds |
12/10/2003 | CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using |
12/10/2003 | CN1460506A Blumea soft capsule and its preparation method |
12/10/2003 | CN1460495A Medicine for curing hyperplasia disease of mamary glands |
12/10/2003 | CN1460482A Medicine composite containing icaritin and demethylicaritin and its application |
12/10/2003 | CN1460476A Apomorphine sublingual dripping pill preparation with adjustable medicine-releasing rate |
12/10/2003 | CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use |
12/10/2003 | CN1130355C Thienyl-, furyl-, pyrrolyl-and biphenylsulfonamides and derivatives thereof modulate activity of endothelin |
12/10/2003 | CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent |
12/10/2003 | CN1130209C Chinese medicine composition for curing sterility |
12/10/2003 | CN1130208C Preparation for curing sexual impotence caused by inflammation of genital system |
12/10/2003 | CN1130206C Mampalon penis product |
12/09/2003 | US6660891 Methods for the production of D-chiro-inositol and the use of D-chiro inositol obtained therefrom |
12/09/2003 | US6660859 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases |
12/09/2003 | US6660746 Cardiovascular disorders |
12/09/2003 | US6660744 Pyrazolopyrimidines as therapeutic agents |
12/09/2003 | US6660738 Such as (3R,5S)-1-pyrimidin-2-yl-5-(2,4,5-trifluoro-benzyloxymethyl)-pyrrolidine-3 -thiol trifluoro-acetate useful as inhibitors of metalloproteases for treating diseases associated with vasoconstriction |
12/09/2003 | US6660717 Folliculogenesis |
12/06/2003 | CA2431338A1 Method for preventing decrease of breast milk amount in mammals |
12/04/2003 | WO2003100025A2 Crisp polypeptides as contraceptives and inhibitors of sperm capacitation |
12/04/2003 | WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof. |
12/04/2003 | WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
12/04/2003 | WO2003099818A1 Substituted quinazolinone compounds |
12/04/2003 | WO2003099786A2 Aromatic sulfones and their medical use |
12/04/2003 | WO2003099783A2 Tropane compounds |
12/04/2003 | WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
12/04/2003 | WO2003099771A2 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
12/04/2003 | WO2003099764A1 ALKOXY ARYL β2 ADRENERGIC RECEPTOR AGONISTS |
12/04/2003 | WO2003099337A2 Inclusion complexes of rosiglitazone |
12/04/2003 | WO2003099333A1 Methods of controlling fertility, cancers and reproductive tract diseases |
12/04/2003 | WO2003099292A1 Treatment of post-menopausal complaints in breast cancer patients comprising tibolone and a serm |
12/04/2003 | WO2003099291A1 Progestagenic dosage units |
12/04/2003 | WO2003099284A1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
12/04/2003 | WO2003099279A1 Combination of a dpp iv inhibitor and a cardiovascular compound |
12/04/2003 | WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
12/04/2003 | WO2003099201A2 Compositions and methods of use for a fibroblast growth factor |
12/04/2003 | WO2003075921A3 Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
12/04/2003 | WO2003064596A3 Desaturase genes, enzymes encoded thereby, and uses thereof |
12/04/2003 | WO2003064460A8 Two gonadotropin releasing hormones and a method to isolate the same |
12/04/2003 | WO2003030878A3 Galenic microparticulate oral formulation |
12/04/2003 | WO2003028715A3 Methods using 1, 2-dithiol-3-thiones and their derivatives and metabolites for inhibiting angiogenesis |
12/04/2003 | WO2003027085A3 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
12/04/2003 | WO2003021273A3 Diagnosis of carcinomas |
12/04/2003 | WO2003017991A3 Injection solution containing a dihydropyridin derivative |
12/04/2003 | WO2003006996A3 Natural ligand of gpcr chemr23 and uses thereof |
12/04/2003 | WO2003005954B1 Methods and materials for the treatment of testosterone deficiency in men |
12/04/2003 | WO2002102310A3 Proteins associated with cell growth, differentiation, and death |
12/04/2003 | WO2002094186A3 Urazole compounds useful as anti-inflammatory agents |
12/04/2003 | WO2002082077A3 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
12/04/2003 | WO2002068397A8 Diaminoquinazoline esters for use as dihydrofolate reductade inhibitors |
12/04/2003 | US20030225272 Novel mmp-2/mmp-9 inhibitors |
12/04/2003 | US20030225266 N-aromatic or heteroaromatic-oxyalkylene, hydrocarbylnamide derivatives useful for potentiating glutamate receptor function; Alzheimer's Disease; antidepressants; cognition activators; psychosis; psychiatric and neurological disorders |
12/04/2003 | US20030225151 Pyrazole compositions useful as inhibitors of ERK |
12/04/2003 | US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
12/04/2003 | US20030225128 For treating conditions such as erectile dysfunction, cardiovascular disorders, male or female sexual dysfunction, diabetes mellitus, and gastrointestinal disorders |
12/04/2003 | US20030225120 Dihydropyridine soft drugs, and related compositions and methods |
12/04/2003 | US20030225116 Substituted 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridine |
12/04/2003 | US20030225113 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies. |
12/04/2003 | US20030225111 Use of a quinazoline derivative such as 1-(2,6-dichloro-phenyl)-3-(7-(3-morpholinopropoxy)quinazolin-4-yl) urea to produce an antiangiogenic and/or vascular permeability reducing effect |
12/04/2003 | US20030225109 Inducing contraception, treat progesterone-related carcinomas and adenocarcinomas; hormone replacement therapy |
12/04/2003 | US20030225106 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
12/04/2003 | US20030225094 E.g, 4-(2-((6R,12aR)-6-benzo(1,3)dioxol-5-yl-1,4-dioxo -3,4,6,7,12,12a-hexahydro-1H-pyrazino-(1',2':1,6)pyrido(3,4-b) indol-2-yl)ethyl)-benzenesulfonamide; inhibitors of cyclic guanosine 3', 5'-monophosphate specific phosphodiesterase |